Financial results - PRO MED VITA SRL

Financial Summary - Pro Med Vita Srl
Unique identification code: 30910261
Registration number: J22/1946/2012
Nace: 7500
Sales - Ron
180.068
Net Profit - Ron
37.006
Employee
2
The most important financial indicators for the company Pro Med Vita Srl - Unique Identification Number 30910261: sales in 2023 was 180.068 euro, registering a net profit of 37.006 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati veterinare having the NACE code 7500.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Pro Med Vita Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 20.112 24.760 25.396 30.357 28.776 30.065 27.496 114.621 165.569 180.068
Total Income - EUR 20.121 24.877 26.036 30.382 28.776 30.270 27.496 114.711 165.742 180.068
Total Expenses - EUR 17.327 21.645 22.625 26.450 26.207 27.350 29.295 97.489 129.344 141.531
Gross Profit/Loss - EUR 2.795 3.232 3.411 3.932 2.569 2.919 -1.800 17.222 36.397 38.537
Net Profit/Loss - EUR 2.191 1.954 3.161 3.629 2.282 2.616 -1.965 16.179 34.989 37.006
Employees 1 2 2 0 2 1 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 9.1%, from 165.569 euro in the year 2022, to 180.068 euro in 2023. The Net Profit increased by 2.123 euro, from 34.989 euro in 2022, to 37.006 in the last year.

Check the financial reports for the company - Pro Med Vita Srl

Rating financiar

Financial Rating -
Pro Med Vita Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Pro Med Vita Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pro Med Vita Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Pro Med Vita Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pro Med Vita Srl - CUI 30910261

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 100 727 667 605 447 389 334 279 921 438
Current Assets 4.774 6.449 8.992 12.291 13.440 16.054 13.854 33.885 65.967 91.952
Inventories 1.401 1.626 2.799 4.078 3.925 6.344 7.164 11.569 20.408 35.456
Receivables 954 447 1.035 1.017 1.407 4.163 2.080 2.617 2.648 2.353
Cash 2.419 4.375 5.159 7.196 8.108 5.547 4.610 19.699 42.911 54.144
Shareholders Funds 2.550 4.526 7.573 11.030 12.152 14.533 12.292 24.944 58.164 78.518
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 2.324 2.649 2.086 1.866 1.735 1.910 1.895 9.220 8.724 13.873
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 91.952 euro in 2023 which includes Inventories of 35.456 euro, Receivables of 2.353 euro and cash availability of 54.144 euro.
The company's Equity was valued at 78.518 euro, while total Liabilities amounted to 13.873 euro. Equity increased by 20.530 euro, from 58.164 euro in 2022, to 78.518 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Pro Med Vita Srl

Comments - Pro Med Vita Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.